abstract Serous cells are the predominant site of cystic fibrosis transmembrane conductance regulator expression in the airways, and they make a significant contribution to the volume, composition, and consistency of the submucosal gland secretions. We have employed the human airway serous cell line Calu-3 as a model system to investigate the mechanisms of serous cell anion secretion. Forskolin-stimulated Calu-3 cells secrete by a Cl Ϫ -independent, serosal Na ϩ -dependent, serosal bumetanide-insensitive, and serosal 4,4 Ј -dinitrostilben-2,2 Ј -disulfonic acid (DNDS)-sensitive, electrogenic mechanism as judged by transepithelial currents, isotopic fluxes, and the results of ion substitution, pharmacology, and pH studies. Similar studies revealed that stimulation of Calu-3 cells with 1-ethyl-2-benzimidazolinone (1-EBIO), an activator of basolateral membrane Ca 2 ϩ -activated K ϩ channels, reduced secretion and caused the secretion of Cl Ϫ by a bumetanide-sensitive, electrogenic mechanism. Nystatin permeabilization of Calu-3 monolayers demonstrated 1-EBIO activated a charybdotoxin-and clotrimazoleinhibited basolateral membrane K ϩ current. Patch-clamp studies confirmed the presence of an intermediate conductance inwardly rectified K ϩ channel with this pharmacological profile. We propose that hyperpolarization of the basolateral membrane voltage elicits a switch from secretion to Cl Ϫ secretion because the uptake of across the basolateral membrane is mediated by a 4,4 Ј -dinitrostilben-2,2 Ј -disulfonic acid (DNDS)-sensitive Na ϩ :
n t r o d u c t i o n
The inherited disease cystic fibrosis (CF) 1 is characterized by secretion of a thick viscous mucus that plugs the submucosal glands and small airways. This leads to chronic airway infections and is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) (Boat et al., 1989) . The predominant site of CFTR expression in the human lung is the serous cells of the submucosal glands (Jacquot et al., 1993; Engelhardt et al., 1994) . Serous cells account for 60% of the cellular volume of the submucosal gland in human airways (Basbaum et al., 1990) . Stimulation of an isotonic fluid secretion from the serous cells contributes to the hydration of the secretions from the mucous cells, thereby forming the low viscosity mucus that lines the conducting airways. Serous cells are also a major source of antimicrobial enzymes and peptides that help maintain an aseptic environment in the lungs (Basbaum et al., 1990) . Salt concentration can influence the activity of these antimicrobial agents and it was recently suggested that altered salt concentration in the airway surface fluid may contribute to chronic airway infection in CF (Smith et al., 1996) . Thus, the serous cells make a significant contribution to the volume, composition, and consistency of the submucosal gland secretions and represent a potentially important target in CF therapy. These considerations indicate the importance in understanding the mechanisms of fluid and electrolyte transport by serous cells. Shen et al. (1994) screened 12 cell lines derived from lung adenocarcinomas in an attempt to identify a cell line that displayed electrophysiological properties consistent with human airway serous cells. They identified the Calu-3 cell line as being serous cell in nature, forming a monolayer with a transepithelial resistance of ‫ف‬ 100 ⍀ и cm 2 , expressing high levels of CFTR and responding to both cAMP-and Ca 2 ϩ -mediated agonists with changes in net transepithelial ion transport as measured by short circuit current (I sc ) (Finkbeiner et al., 1993; Shen et al., 1994) . Several studies have produced variable results in the basal and stimulated transport properties of the Calu-3 cells and the ionic basis of the responses to secretory agonists remains unsettled (Shen et al., 1994; Illek et al., 1997; Moon et al., 1997; Singh et al., 1997; Lee et al., 1998) . In this report, we present studies with Calu-3 cells that displayed a low basal I sc (13 A cm Ϫ 2 ) and robust sustained responses to secretory agonists enabling the measurement of isotopic fluxes. The results demonstrate that Calu-3 cells, when stimulated by forskolin, secrete by a Cl Ϫ -independent, Na ϩ -dependent, 4,4 Ј -dinitrostilben-2,2 Ј -disulfonic acid (DNDS)-sensitive, electrogenic mechanism. Secondly, when stimulated by 1-ethyl-2 benzimidazolinone (1-EBIO), an activator of the basolateral membrane Ca 2 ϩ -activated K ϩ channels (K Ca ) (Devor et al., 1996) , secretion is reduced and the Calu-3 cells secrete predominately Cl Ϫ by a bumetanide-sensitive, electrogenic mechanism.
m e t h o d s

Cell Culture
Calu-3 cells were grown in Dulbecco's modified Eagle's medium and Ham's F-12 (1:1) supplemented with 15% fetal bovine serum and 2 mM glutamine. The cells were incubated in a humidified atmosphere containing 5% CO 2 at 37 Њ C. For measurements of short-circuit current (I sc ), Calu-3 cells were seeded onto Costar Transwell cell culture inserts (0.33 cm 2 ) or Snapwell inserts (1.1 cm 2 ). Both the Transwell and Snapwell inserts were collagencoated overnight with 0.01% human placenta collagen type VI (Sigma Chemical Co.). On day one, the medium bathing the apical surface was removed to establish an air interface. Apical medium was removed and the cells fed every 48 h. After ‫ف‬ 7-14 d, the cells formed a confluent monolayer that held back fluid, thus maintaining an apical air interface. Short circuit current measurements were performed after an additional 14-28 d in culture. Patch-clamp experiments were performed on single cells plated onto glass cover slips 18-48 h before use.
Solutions
For measurements of I sc , the bath solution contained (mM): 120 NaCl, 25 NaHCO 3 , 3.3 KH 2 PO 4 , 0.8 K 2 HPO 4 , 1.2 MgCl 2 , 1.2 CaCl 2 , and 10 glucose. Mannitol was substituted for glucose in the mucosal solution to eliminate the contribution of Na ϩ glucose cotransport to I SC as previously reported by Singh et al. (1997) . The pH of this solution was 7.4 when gassed with a mixture of 95% O 2 -5% CO 2 at 37 Њ C. For the Cl Ϫ -free solution, equimolar Na-gluconate replaced NaCl, 1 mM Mg-gluconate replaced MgCl 2 , and 4 mM Ca-gluconate replaced CaCl 2 . Calcium was increased to 4 mM to compensate for the Ca 2 ϩ buffering ca-
pacity of the gluconate. The -free buffer consisted of (mM): 145 NaCl, 3.3 KH 2 PO 4 , 0.8 K 2 HPO 4 1.2 MgCl 2 , 1.2 CaCl 2 , 10 HEPES, pH adjusted with NaOH, 10 glucose or mannitol and was gassed with air. For the Na ϩ -free Cl Ϫ -free solution, equimolar N -methyl-d -glucamine-gluconate replaced NaCl, choline-HCO 3 replaced NaHCO 3 , 1 mM Mg-gluconate replaced MgCl 2 , and 4 mM Ca-gluconate replaced CaCl 2 . This solution contained 10 M atropine to block the cholinergic effect of choline (Muallem et al., 1988) .
The effects of forskolin and 1-EBIO on apical membrane Cl Ϫ currents (I Cl ) were assessed after permeabilization of the serosal membrane with nystatin (360 g/ml), and the establishment of a mucosa-to-serosa Cl Ϫ concentration gradient. Serosal NaCl was replaced by equimolar Na-gluconate and Ca 2 ϩ was increased to 4 mM with Ca-gluconate. Nystatin was added to the serosal membrane 15-30 min before the addition of drugs. Successful permeabilization of the basolateral membrane was based upon the recording of a current consistent with the mucosal-to-serosal flow of negative charge. The effect of 1-EBIO on basolateral membrane K ϩ currents (I K ) was assessed after permeabilization of the apical membrane with nystatin (180 g/ml) for 15-30 min, and establishment of a mucosa-to-serosa K ϩ concentration gradient. For measurements of I K , mucosal NaCl was replaced by equimolar K-gluconate, while serosal NaCl was substituted with equimolar Na-gluconate. Calcium and Mg 2 ϩ salts were replaced as above.
During inside-out patch-clamp recordings, the bath contained (mM): 145 K-gluconate, 5 KCl, 1 MgCl 2 , 1 EGTA, 0.78 CaCl 2 , (free Ca 2 ϩ ϭ 400 nM), and 10 HEPES, pH adjusted to 7.2 with KOH. The pipette solution contained (mM): 140 K-gluconate, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , and 10 HEPES, pH adjusted to 7.2 with KOH. For outside-out recordings, the bath contained 1 mM CaCl 2 in the absence of any added EGTA, while the pipette solution Ca 2 ϩ was buffered to 200 nM with EGTA (0.71 mM Ca 2 ϩ , 1 mM EGTA).
Short-Circuit Current (I sc ) Measurements
Transwell inserts were mounted in an Ussing chamber (Jim's Instruments). Snapwell inserts were mounted in Ussing chambers (NaviCyte), and the monolayers were continuously short-circuited after fluid resistance compensation using automatic voltage clamps (558C-5; Iowa Bioengineering). Transepithelial resistance (R T ) was measured by open-circuiting the monolayer, or with a 2-mV bipolar pulse and the resistance calculated by Ohm's law. Forskolin, 1-EBIO, clotrimazole, 293B, and acetazolamide were added to both sides of the monolayers at the indicated concentrations. Bumetanide and char ybdotoxin (CTX) were added only to the serosal bathing solution.
Unidirectional Ion Fluxes
20 min after the Snapwell filters were mounted in Ussing chambers, isotopes ( 36 Cl, 22 Na, or 86 Rb) were added to the bath solution on one side of the monolayers. After an additional 20 min, by which time isotopic fluxes had reached a steady state, two 0.4-ml samples were taken from the unlabeled side and fresh unlabeled solution of equal volume was added. This time was considered time ϭ 0 (T 0 ), and samples were taken thereafter at 15-min intervals for the next 75 min. When the effects of forskolin, 1-EBIO, or forskolin plus 1-EBIO were studied, the drugs were added to the serosal and mucosal sides at T 30 and fluxes before (T 0 Ϫ T 30 ) and 15 min after the drug additions (T 45 Ϫ T 75 ) were compared. Isotope activities were determined in a Packard liquid scintillation counter. All samples were weighed and these volumes were used to correct the chamber volume and to calculate the unidirectional ion fluxes using standard equations (Bridges et al., 1983) . The net residual ion flux ( ) was calculated from 
Single Channel Recording
Single channel currents were recorded in the inside-out and outside-out patch-clamp recording configuration using a List EPC-7 amplifier (Medical Systems) and recorded on videotape for later analysis as described previously (Devor and Frizzell, 1993) . Pipettes were fabricated from KG-12 glass (Willmad Glass Co.). All recordings were done at a holding voltage of Ϫ100 mV. The voltage is referenced to the extracellular compartment as the standard method for membrane potentials. Inward currents are defined as the movement of positive charge from the extracellular compartment to the intracellular compartment, and are presented as downward deflections from baseline in all recording configurations. Single channel analysis was performed on records sampled after low-pass filtering at 400 Hz. Data records for all experimental conditions were at least 60-s long. The nP o (the product of the number of channels, n, and the channel open probability, P o ) of the channels was determined using Biopatch software (3.11; Molecular Kinetics). nP o was calculated from the mean total current (I) divided by the single channel current amplitude (i), such that nP o ϭ I/i. i was determined from the amplitude histogram of the current record.
Chemicals
Nystatin was a generous gift from Dr. S. Lucania (Bristol MeyersSquibb). 293B (trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl-chroman) was a generous gift from Dr. Rainer Greger (Albert-Ludwigs-Universtat, Freiberg, Germany). 1-EBIO was obtained from Aldrich Chemical Co. Acetazolamide, clotrimazole, and bumetanide were obtained from Sigma Chemical Co. Forskolin was obtained from Calbiochem. DNDS was from Pfaltz and Bauer. Charybdotoxin was obtained from Accurate Chemical and Scientific Corp. and made as a 10 M stock solution in standard bath solution. 1-EBIO, 293B, and clotrimazole were made as Ͼ1,000-fold stock solutions in DMSO. Nystatin was made as a 180 mg/ml stock solution in DMSO and sonicated for 30 s just before use. Forskolin and bumetanide were made as 1,000-fold stock solutions in ethanol. Cell culture medium was obtained from GIBCO BRL.
Data Analysis
All data are presented as means Ϯ SEM, where n indicates the number of experiments. r e s u l t s
Effects of Forskolin on I sc
In total, we evaluated 216 filters with standard bath solutions on the mucosal and serosal membrane surfaces. The basal I sc and R T under these conditions averaged 13 Ϯ 0.8 A и cm Ϫ2 (range 2-21 A и cm Ϫ2 ) and 353 Ϯ 14 ⍀cm 2 (range 187-667 ⍀cm 2 ), respectively. Forskolin (2-10 M) induced, in all filters tested (n ϭ 109), a damped oscillatory response that became stable and sustained after 5-10 min at a plateau value of 66 Ϯ 4 A и cm Ϫ2 (range 50-103 A и cm Ϫ2 ). A representative current trace is shown in Fig. 1 A. The increase in I sc caused by forskolin was accompanied by a decrease in ). Bumetanide (20 M), an inhibitor of the NaK2Cl cotransporter, caused only a small inhibition of the forskolin stimulated I sc (⌬ Ϫ4.9 Ϯ 1.3 A и cm Ϫ2 , n ϭ 11). The failure of bumetanide to inhibit the forskolin-stimulated increase in I sc suggests that the NaK2Cl cotransporter does not contribute to the I sc , and this raised the question whether the I sc was due to Cl Ϫ secretion. Additional experiments were performed to establish the ionic basis of the forskolin-stimulated I sc .
Effects of Forskolin on Isotopic Fluxes
To help elucidate the ionic basis of the forskolininduced increase in I sc , we performed unidirectional ion flux measurements with 36 Cl, 22 Na, or 86 Rb; the latter was used as a measure of K ϩ movements. The Cl Ϫ flux studies are shown in Fig. 1 B and are summarized together with Na ϩ and Rb ϩ fluxes in Table I . As in the previous experiments, there was a small basal I sc under control conditions of ‫8ف‬ A и cm Ϫ2 (i.e., 0.3 Eq и cm Ϫ2 и h Ϫ1 ) that was stimulated 6-10-fold by forskolin in the subset of 36 filters used for the flux studies. Under control conditions, there was no net movement of Cl Ϫ or Rb ϩ and a small net absorption of Na ϩ . Forskolin increased both unidirectional fluxes of Cl Ϫ four-to fivefold ( Fig. 1 B) . Both Rb ϩ fluxes were increased 1.5-fold, but forskolin had no effect on the fluxes of Na ϩ (Table I) . Because both unidirectional fluxes of Cl Ϫ and Rb ϩ were increased to a similar extent, there was no net flux of Cl Ϫ or Rb ϩ caused by forskolin. The difference between I sc and the net flux of each ion was calculated and is given in Table I as . Because there was no net flux of Cl Ϫ or Rb ϩ under control or forskolin conditions, neither of these ions account for the basal or forskolin-stimulated I sc . However, the net absorption of Na ϩ fully accounts for the control, basal I sc , and a small portion (15%) of the I sc in the forskolinstimulated cells. When the flux studies for Cl Ϫ , Na ϩ , and Rb ϩ were combined to calculate the using the mean I sc (control 0.31 Ϯ 0.053 Eq и cm Ϫ2 и h Ϫ1 ; forskolin 2.60 Ϯ 0.144 Eq и cm Ϫ2 и h Ϫ1 , n ϭ 36) for the studies in Table I , the control was Ϫ0.12 Ϯ 0.11 Eq и cm Ϫ2 и h Ϫ1 and the forskolin was 2.37 Ϯ 0.189 Eq и cm Ϫ2 и h Ϫ1 . These results demonstrate that the forskolin-induced increase in I sc cannot be accounted for by the net transepithelial secretion of Cl Ϫ or the absorption of Na ϩ or K ϩ . Rather, the increase in I sc caused by forskolin must be attributed to the net movement of an unmeasured ion, often referred to as the net residual ion flux, . Because is the only remaining ion of significant concentration, is likely to be due to the net secretion of and additional experiments were performed to test this hypothesis.
Anion Secretion in Calu-3 Cells
Ion Substitution Studies
Ion substitution experiments were performed to help further establish the ionic basis of the forskolin-stimulated I sc . Consistent with the failure of bumetanide to inhibit the forskolin-stimulated I sc and the of only 0.09 Ϯ 0.257 Eq и cm Ϫ2 и h Ϫ1 , substitution of Cl Ϫ with gluconate caused only a partial reduction of the response to forskolin (Fig. 2 A) . Similar to the control response, the I sc response to forskolin in Cl Ϫ -free solution was rapid in onset with a transient peak and a sustained plateau of 46 Ϯ 1.6 A и cm Ϫ2 (n ϭ 24) (Fig. 2  A) . The subsequent addition of Cl Ϫ (30-60 mM) to the J Cl net mucosal or serosal solution did not cause a further increase in I sc (data not shown). As in the Cl Ϫ containing solution, bumetanide (20 M serosal) had no effect on the forskolin-stimulated I sc (⌬ 0.15 Ϯ 0.76 A и cm Ϫ2 , n ϭ 6) ( Fig. 3) . In contrast, removal of from the mucosal and serosal bathing solutions resulted in a greatly diminished response to forskolin (Fig. 2 B) . After a transient response, I sc was increased by only 4 Ϯ 1 A и cm Ϫ2 (n ϭ 10) in -free solutions. Substitution of Na ϩ with N-methyl-d-glucamine, Cl Ϫ with gluconate, and NaHCO 3 with choline HCO 3 also resulted in a greatly reduced response to forskolin. Forskolin Flux values and I sc are in eq cm Ϫ2 h Ϫ1 , and resistance (R T ) in ⍀cm 2 . Measurements were made before and after the addition of forskolin (2 M) to the mucosal (m) and serosal (s) solutions. Values are the mean Ϯ SEM, n ϭ 6 for each unidirectional flux and 12 for J net , I sc , R T , and . See text for explanation of .
caused a transient increase in I sc without a sustained plateau in the Na ϩ -free, Cl Ϫ -free, -containing solution (Fig. 2 C) , which resembles the response in -free media. However, the subsequent addition of Na ϩ (30 mM) to the serosal but not the mucosal solution caused a sustained increase in I sc of 24 Ϯ 1.0 A и cm Ϫ2 (n ϭ 12) in forskolin-stimulated cells (Fig. 4) . Addition of Na ϩ (30 mM) to the serosal solution before forskolin caused a small decrease in I sc ⌬ Ϫ7.6 Ϯ 0.2 A и cm Ϫ2 (n ϭ 12) as expected for the serosal-
to-mucosal diffusion of a cation. This decrease in I sc was reversed and I sc rose to a sustained level of 23 Ϯ 0.8 A и cm Ϫ2 (n ϭ 12) with the subsequent addition of forskolin. Thus, the forskolin-stimulated increase in the I sc was Cl Ϫ independent but Na ϩ and dependent.
Pharmacology Studies
The above results are consistent with forskolin-stimulated net secretion of . To further test this hy-
Figure 2. Forskolin effects on Calu-3 cell I sc in nominally Cl Ϫ -free (A), -free (B), or Na ϩ -free (C) buffers. Note the lack of a sustained forskolin (2 M)-stimulated increase in I sc in the -free and Na ϩ -free buffers. Current traces are representative of 12-24 experiments with similar results. pothesis, the pharmacological sensitivity to various inhibitors of transport were evaluated. The carbonic anhydrase inhibitor, acetazolamide (1 mM mucosal and serosal), caused a 27% decrease (a reduction of 13 Ϯ 1 A cm 2 , n ϭ 6) in the forskolin-stimulated I sc in Cl Ϫ -free solutions (Fig. 3) . DNDS (3 mM), an inhibitor of Cl Ϫ / exchangers and Na ϩ : cotransporters, was without effect when added to the mucosal solution (⌬ ϭ 0.2 A и cm Ϫ2 , n ϭ 6), but caused an inhibition of 56% (⌬ Ϫ26 Ϯ 1 A и cm Ϫ2 , n ϭ 6) when added to the serosal side in Cl Ϫ -free solutions. Similar results were obtained in Cl Ϫ -containing solutions (⌬ Ϫ2.5 Ϯ 1.3 A и cm Ϫ2 , n ϭ 6 mucosal; ⌬ Ϫ27 Ϯ 2 A и cm Ϫ2 , n ϭ 6 serosal). The half maximal inhibitory concentration (K i ) for serosal DNDS was 300 M. The inhibitory effects of serosal DNDS and acetazolamide were additive, together causing a 75% decrease in I sc . The Na ϩ -K ϩ -ATPase inhibitor, ouabain (100 M), caused an immediate and complete inhibition of the forskolin-stimulated I sc . Neither CTX (50 nM), a blocker of Ca 2ϩ activated K ϩ channels (Garcia et al., 1995) , nor 293B (100 M), a blocker of the cAMP/ PKA activated K ϩ channel (KvLQT1; Lohrmann et al., 1995; Loussouarn et al., 1997) inhibited the forskolinstimulated I sc . The nonselective K ϩ channel blocker, Ba 2ϩ (5 mM serosal side), inhibited the forskolin-stimulated I sc by only 10 Ϯ 2 A и cm Ϫ2 (n ϭ 6).
The requirement for serosal Na ϩ , the inhibition by ouabain, and the partial inhibition by serosal DNDS suggests some of the secreted is mediated by the
uptake of across the basolateral membrane on a Na ϩ :
cotransporter. 2 The partial inhibition of I sc by acetazolamide suggests some of the secreted originates from a metabolic source. The Cl Ϫ independence and the failure of mucosal DNDS to inhibit I sc suggests the exit of across the apical membrane is not mediated by a Cl Ϫ / exchanger.
pH Studies
The above results are consistent with the conclusion that forskolin stimulation causes the electrogenic secretion of . To further test this hypothesis, we performed experiments to determine whether forskolin caused an alkalinization of the apical solution. Calu-3 cells were studied under open circuit conditions with a small volume of fluid (100 l) on the apical surface (1.1 cm 2 ) and 5 ml of continuously gassed (95% O 2 / 5% CO 2 ) NaCl, NaHCO 3 buffer, pH 7.4, on the serosal side. Cells were incubated without or with forskolin (2 M) and the apical solution collected after 90 min. The apical sample was thoroughly gassed before mea- buffer. Cells were stimulated with forskolin (2 M) either before (A) or after (B) the addition of 30 mM Na-gluconate to the serosal solution. Note that forskolin failed to cause a sustained increase in I sc in the absence of serosal Na. Mucosal Na (30 mM) had no effect on the forskolin-stimulated I sc . Current traces are representative of 6-12 experiments with similar results. White (1989) has reported a complete inhibition by 1 mM DNDS of a Na ϩ :
cotransporter in the basolateral membrane of salamander intestine. Newman (1991) has reported a 73% inhibition by 2 mM DNDS of a Na ϩ : cotransporter in retinal glial cells of the salamander. Although perhaps not directly comparable, Boron and Knakal (1989) reported a DNDS K i of 300 M of a Na ϩ -and Cl Ϫ -dependent cotransporter in the squid axon.
suring its pH with a miniature pH electrode. Studied in this manner, we found forskolin caused an alkalinization of the apical solution to a pH of 7.8 Ϯ 0.06 (n ϭ 6), whereas control untreated filters showed a small acidification of the apical solution, pH 7.3 Ϯ 0.05 (n ϭ 6). The forskolin-stimulated alkalinization of ⌬0.5 pH over a 90-min period corresponds to the net movement of of 1.7 eq и cm Ϫ2 и h Ϫ1 or 46 A и cm Ϫ2 , a value in good agreement with the forskolin-stimulated increase in I sc of 53 A и cm Ϫ2 under short circuit conditions. 3 Based on these pH measurements, the ion flux measurements, the ion substitution studies, and the pharmacology studies, we conclude that the forskolin-induced I sc response in Calu-3 cells is due to the net secretion of by a Cl Ϫ -independent Na ϩ -dependent, and DNDS-sensitive electrogenic mechanism.
Effects of 1-EBIO on Calu-3 Cells
We previously demonstrated that the novel benzimidazolinone, 1-EBIO, induced a sustained transepithelial Cl Ϫ secretory response in rat colonic mucosa, human colonic T84 cells, and murine airway epithelia (Devor et , 1996) . CTX and clotrimazole inhibited the 1-EBIOstimulated Cl Ϫ secretion consistent with the activation of basolateral membrane K ϩ channels that was confirmed in permeabilized monolayers (Devor et al., 1996 (Devor et al., , 1997 . Moreover, patch clamp studies demonstrated 1-EBIO activates an inwardly rectifying, calcium activated, CTX, and clotrimazole-sensitive K ϩ channel (Devor et al., 1996 (Devor et al., , 1997 . Permeabilized monolayers revealed 1-EBIO also activates an apical membrane Cl Ϫ conductance (Devor et al., 1996) . The studies reported here were performed to determine if 1-EBIO would have similar effects on Calu-3 cells.
In 46 experiments, 1-EBIO (1 mM) increased I sc from a basal value of 8 Ϯ 0.8 to 62 Ϯ 4 A и cm Ϫ2 with only a modest decrease in R T (control 397 Ϯ 21 ⍀cm 2 vs. 1-EBIO 336 Ϯ 20 ⍀cm 2 ). A current trace of a typical I sc response to 1-EBIO is shown in Fig. 5 A. The response was rapid in onset and sustained over a long period. Dose-response studies revealed the half maximal effective concentration of 1-EBIO was ‫005ف‬ M. Consistent with the activation of the K Ca channels, CTX (50 nM) inhibited 47% of the 1-EBIO-stimulated I sc . The half maximal effective concentration of CTX was 3.2 nM (n ϭ 4). Clotrimazole (10 M), a nonpeptide inhibitor of K Ca , also inhibited 87.6 Ϯ 1.9% (n ϭ 5) of the response to 1-EBIO with a K i of 1.2 M (n ϭ 5). Bumetanide (20 M) inhibited ‫%05ف‬ of the 1-EBIO-stimulated I sc (Table II) . DNDS and acetazolamide caused only small (Ͻ10%) decreases in the 1-EBIO-stimulated I sc .
Unidirectional fluxes of 36 Cl revealed that 1-EBIO caused the net secretion of Cl Ϫ (Fig. 5 B and Table II) . As in previous experiments (Fig. 1 B) , there was no net 3 The net secretion of can be calculated from the equation J (mol и cm Ϫ2 и h Ϫ1 ) ϭ buffer capacity (␤ CO2 ) и ⌬pH и h Ϫ1 и volume и area Ϫ1 , where ␤ CO2 ϭ 2.3 (25 mM ), final volume ϭ 100 l, and area ϭ 1.1 cm 2 . Thus, J HCO3 ϭ 57.5 и 0.33 ⌬pH и h Ϫ1 и 0.1 ϫ 10 Ϫ3 liters и 1.1 cm Ϫ2 ϭ 1.7 eq и cm Ϫ2 и h Ϫ1 . Although the final volume was not measured, it was consistently greater in the forskolin-stimulated monolayers compared with the control monolayers. Therefore, the actual net flux of would be proportionally higher and be in even closer agreement with the forskolin-stimulated increase in I sc . Note that 1-EBIO caused a sixfold increase in J sm , no change in J ms , and a net secretion of Cl Ϫ that, as summarized in Table II , was nearly equal to the increase in I sc . The 1-EBIO-stimulated secretion of Cl Ϫ was inhibited by bumetanide (Table II) , as anticipated from the inhibition in I sc . Fluxes are plotted as the absolute values. secretion of Cl Ϫ in control monolayers. 1-EBIO caused a sixfold increase in the serosal-to-mucosal flux of Cl Ϫ without altering the mucosal-to-serosal flux leading to net Cl Ϫ secretion. Moreover, the net secretion of Cl Ϫ fully accounted for the increase in I sc caused by 1-EBIO, leaving a small of only 0.25 Ϯ 0.263 Eq и cm Ϫ2 и h Ϫ1 . Bumetanide inhibited the serosal-to-mucosal flux of Cl Ϫ and thereby caused a 70% inhibition in in 1-EBIO-stimulated monolayers.
Effects of Forskolin and 1-EBIO on I sc
The above results demonstrate Calu-3 cells secrete when stimulated by forskolin and Cl Ϫ when stimulated by 1-EBIO. In the next series of experiments, we evaluated the effects of 1-EBIO on forskolin stimulated monolayers. As in the previous experiments, forskolin increased I sc from a control value of 6.8 Ϯ 0.7 to 67 Ϯ 4.3 A и cm Ϫ2 (n ϭ 12) without causing the net
secretion of Cl Ϫ and leaving a nearly equal to the change in I sc (Fig. 6 and Table III) . 1-EBIO further increased I sc to 114 Ϯ 5 A и cm Ϫ2 (Fig. 6 and Table III) . Similar results were obtained if the order of the addition of forskolin and 1-EBIO were reversed. CTX inhibited 79 Ϯ 2% (n ϭ 8) and bumetanide inhibited 80 Ϯ 1% (n ϭ 5) of the forskolin plus 1-EBIO-stimulated I sc . When added to the forskolin-stimulated cells, 1-EBIO caused a twofold increase in the serosal-to-mucosal flux of Cl Ϫ and a that was nearly equal to the I sc ( Fig. 6 and Table III) . Thus, 1-EBIO caused a 70% decrease in the forskolin-stimulated . These results suggest 1-EBIO can switch the forskolin-stimulated Calu-3 cells from -to Cl Ϫ -secreting cells. One hypothesis to explain the effects of 1-EBIO on Calu-3 cells is the activation of basolateral membrane K ϩ channels that would tend to hyperpolarize the membrane potential. The inhibition of the 1-EBIO response by CTX and clotrimazole support this hypothe- Units are as given in Table I . Measurements were made before and after the addition of 1-EBIO (1 mM) to the mucosal (m) and serosal (s) Table III. sis. Hyperpolarization of the membrane potential would increase the driving force for anion exit of both and Cl Ϫ across the apical membrane. However, hyperpolarization of the basolateral membrane potential would also tend to decrease the driving force for basolateral membrane entry on the Na ϩ : cotransporter, whose Na ϩ to stoichiometry is reported to be 1:2 or 1:3 in various cell types (Boron and Boulpaep, 1989) . A second hypothesis, and one that is not mutually exclusive with the former hypothesis, is that 1-EBIO activates apical membrane anion channels that were not activated by forskolin and that the 1-EBIOactivated channels allow for the preferential exit of Cl Ϫ over . To test these hypotheses, we performed studies on permeabilized monolayers.
The pore forming antibiotic nystatin was used to permeabilize the apical membrane and a transepithelial mucosal-to-serosal K ϩ gradient was established. After permeabilization, 1-EBIO increased I K , and this was inhibited by both CTX (Fig. 7 A) and clotrimazole (B). In 17 experiments, 1-EBIO (1 mM) increased I K an average of 91 Ϯ 9 A и cm Ϫ2 and this was inhibited 66 Ϯ 2% by CTX (50 nM, n ϭ 10) and 95 Ϯ 2% by clotrimazole (10 M, n ϭ 7). Thus, 1-EBIO does activate basolateral membrane K ϩ channels. In contrast, forskolin (2 M) failed to cause an increase in I K . After the establishment of a mucosal-to-serosal Cl Ϫ gradient, the addition of nystatin to the serosal membrane elicited an absorptive I Cl of 58 Ϯ 9 A и cm Ϫ2 (n ϭ 24, Fig. 8 ). Thus, in contrast to the measurements of I K , treatment of the monolayers with nystatin appears to uncover or activate a substantial basal I Cl . Similar results were observed in T84 cells studied under the same experimental conditions (Devor et al., 1996) . Therefore, this effect of nystatin is not unique to Calu-3 cells. The mechanisms involved in this nystatin induced increase in I Cl are unknown. The subsequent addition of forskolin (10 M) to the nystatin-treated monolayers increased I Cl by an additional 186 Ϯ 15 A и cm Ϫ2 (n ϭ 7) (Fig. 8 A) . 1-EBIO failed to cause any further increase in I Cl in the t a b l e i i i Units are as given in Table I . Measurements were made before and after the addition of 1-EBIO (1 mM) to the mucosal and serosal solutions of forskolin (2 M)-treated monolayers. Values are the mean Ϯ SEM, n ϭ 6 for each unidirectional flux and 12 for J net , I sc , R T , and . forskolin treated monolayers. However, 1-EBIO alone when added to the nystatin-treated monolayers increased I Cl by an additional 74 Ϯ 11 A и cm Ϫ2 (n ϭ 6) and forskolin further increased I Cl by an additional 110 Ϯ 12 A и cm Ϫ2 (n ϭ 6; Fig. 8 B) . Thus, both forskolin and 1-EBIO when added alone can activate an apical membrane Cl Ϫ conductance in nystatin-treated Calu-3 monolayers. Forskolin caused a 2.5-fold greater increase in I Cl compared with the 1-EBIO response. The lack of specific Cl Ϫ channel blockers (Schultz et al., 1999) prevents us from determining whether the same channel or different Cl Ϫ channels are activated by forskolin and 1-EBIO. However, when forskolin and then 1-EBIO was added, the effects on I Cl were not additive, suggesting that forskolin alone can maximally activate the apical Cl Ϫ conductance. Therefore, the effect of 1-EBIO in causing the switch from secretion to Cl Ϫ secretion appears to result from the activation of basolateral membrane K ϩ channels and decreased driving force for entry across the basolateral membrane. This hypothesis will be considered further in the discussion.
Effects of Forskolin and 1-EBIO on Unidirectional and Net Cl
Excised Patch Single Channel Records
The above results indicate that Calu-3 cells express K ϩ channels with similar pharmacological characteristics to the K ϩ channels we described previously in T84 cells (Devor and Frizzell, 1993; Devor et al., 1996 Devor et al., , 1997 and that this conductance may be important in altering the driving force for entry across the basolateral membrane that elicits Cl Ϫ secretion in Calu-3 cells.
Thus, we wished to characterize this K ϩ channel at the single channel level. Inward and outward single-channel currents observed on excision of membrane patches into a symmetric K ϩ bath containing 400 nM free Ca 2ϩ are shown in Fig. 9 A. Channel activity showed no obvious voltage dependence and required Ca 2ϩ in the bath (data not shown). The average current-voltage for four such patches is shown in Fig. 9 B (᭹). Single channel currents were inwardly rectified with average chord conductance values of 31 Ϯ 2 pS at Ϫ100 mV and 9 Ϯ 0.2 pS at ϩ100 mV. The K ϩ -to-Na ϩ selectivity of this channel was assessed by replacing 100 mEq pipette K ϩ with Na ϩ ; P K /P Na was calculated from the Goldman-Hodgkin-Katz relation. Replacing pipette K ϩ with Na ϩ shifted the reversal potential by Ϫ20 mV (n ϭ 4; Fig. 9 B, ᭺) . A shift of Ϫ27 mV is predicted for a perfectly K ϩ selective electrode. From these data, the calculated K ϩ -to-Na ϩ selectivity ratio is 5.5:1. This conductance and K ϩ :Na ϩ selectivity values are similar to what has been previously reported for a Ca 2ϩ -activated K ϩ channel in T84 cells (Devor and Frizzell, 1993; Tabcharani et al., 1994; Roch et al., 1995) as well as primary cultures of canine tracheal epithelial cells (Welsh and McCann, 1985; McCann et al., 1990) .
Effect of 1-EBIO on K Ca
We previously demonstrated that 1-EBIO directly activated the K Ca of T84 cells in excised patch-clamp recordings (Devor et al., 1996) . Thus, we determined whether 1-EBIO would similarly activate K Ca in excised, inside-out single channel patch-clamp recordings from Calu-3 cells. The effect of 1-EBIO (200 M) on one patch is shown in Fig. 10 . Under control conditions (400 nM free Ca 2ϩ in the bath), minimal K Ca channel activity was observed. 1-EBIO produced a large increase in channel activity that was readily reversible after washout of the 1-EBIO. In 14 inside-out recordings, 1-EBIO increased nP o from 0.08 Ϯ 0.02 to 1.68 Ϯ 0.39. These results indicate that this channel, as in T84 cells, is responsible for the increase in the basolateral membrane K ϩ conductance and I sc during an 1-EBIO-mediated secretory response.
Effect of K ϩ Channel Blockers
We demonstrate above that the 1-EBIO-induced basolateral membrane K ϩ conductance is sensitive to block by CTX and clotrimazole (Fig. 7) . We therefore determined whether these inhibitors would block the channel in excised outside-out and inside-out patches. The effect of CTX (50 nM) on K Ca in an outside-out patch is shown in Fig. 11 A. When holding the patch at Ϫ100 mV, addition of CTX to the outside of the channel resulted in a complete inhibition of channel activity. This block was voltage dependent and was partially relieved by voltage clamping the patch to ϩ100 mV. The inhibition by CTX was completely reversible. Similar results were obtained in three additional outside-out patches. Clotrimazole (10 M) also completely inhibited K Ca activity, reducing nP o from 1.59 Ϯ 0.24 to 0.05 Ϯ 0.02 (n ϭ 6; Fig. 11B ). Thus, results from these K ϩ channel blocker experiments further indicate that 1-EBIO is activating this inwardly rectifying Ca 2ϩ -activated K ϩ conductance in Calu-3 monolayers resulting in the stimulation of Cl Ϫ secretion and the inhibition of secretion.
d i s c u s s i o n
The results of our studies with Calu-3 cells demonstrate that forskolin stimulates the net secretion of . Forskolin consistently caused an increase in I sc to a new sustained plateau. Ion flux studies revealed that this increase in I sc could not be explained by the net transport of Na ϩ , Rb ϩ , or Cl Ϫ , leaving secretion as the likely basis for the increase in I sc . Ion substitution experiments demonstrated , but not Cl Ϫ , was required to elicit a sustained increase in I sc with forskolin. In addition, Na ϩ was required in the serosal bath to elicit a forskolin response. Inhibitor studies revealed that the forskolin response was sensitive to ouabain, indicating a role for the Na ϩ /K ϩ -ATPase. The forskolin response was also sensitive to DNDS on the serosal side but not the mucosal side, indicating a role for a basolateral membrane Na ϩ : cotransporter or Cl Ϫ : exchanger. However, because Cl Ϫ was not required and serosal Na ϩ was, the effects of DNDS are likely to result from the inhibition of a basolateral membrane Na ϩ :
cotransporter. Acetazolamide caused a partial inhibition of the forskolin response, consistent with some of the secreted arising from metabolic sources. The ion flux studies failed to show evidence of net secretion of Cl Ϫ in response to forskolin, and bumetanide did not inhibit the I sc response. Thus, forskolin did not cause the net secretion of Cl Ϫ across Calu-3 cells under short circuit conditions. Rather, we conclude forskolin causes the net secretion of by a Cl Ϫ -independent, Na ϩ -dependent, and DNDS-sensitive electrogenic mechanism in Calu-3 cells. The forskolin-stimulated alkalinization of the mucosal bathing solution of Calu-3 cells, studied Although forskolin did not stimulate the net secretion of Cl Ϫ , it did cause a fivefold increase in both unidirectional fluxes of Cl Ϫ (Fig. 1 B and Table I ) and it is of interest to understand the mechanisms that underly these changes. Our first interpretation was that forskolin increased the transcellular passage of Cl Ϫ in both directions. Thus, the opening of CFTR would allow for both the exit and entry of Cl Ϫ across the apical membrane. The NaK2Cl cotransporter in the basolateral membrane would allow the entry of Cl Ϫ leaving one to explain how Cl Ϫ exits the cell in the serosal-to-mucosal direction. However, bumetanide did not alter the unidirectional fluxes, consistent with the lack of change in the forskolin-stimulated I sc . Thus, the NaK2Cl cotransporter does not appear to mediate the entry of Cl Ϫ across the basolateral membrane in the forskolin-stimulated monolayers. We next entertained the possibility that Cl Ϫ may move across the basolateral membrane on a Cl Ϫ :
exchanger. However, the increases in both unidirectional fluxes in response to forskolin were still observed in -free buffer. Thus, the increased fluxes do not depend on extracellular . Because this experiment does not exclude the possibility that a basolateral membrane anion exchanger is operating in a Cl Ϫ :Cl Ϫ exchange mode, we examined the effects of serosal DNDS (1 mM) on the Cl Ϫ fluxes. DNDS cause a 70% decrease in both unidirectional fluxes in the forskolin-stimulated monolayers. Therefore, the increase in Cl Ϫ fluxes caused by forskolin can largely be accounted for by a Cl Ϫ :Cl Ϫ exchange across the basolateral membrane and the exit and entry of Cl Ϫ via CFTR across the apical membrane.
The studies with 1-EBIO demonstrated the Calu-3 cells are not limited to the secretion of , but rather they can also be stimulated to secrete Cl Ϫ . 1-EBIO, like forskolin, consistently caused a sustained increase in I sc . 36 Cl flux studies showed the 1-EBIO-stimulated increase in I sc could be fully accounted for by the net secretion of Cl Ϫ . In addition, both the increase in I sc and the net secretion of Cl Ϫ were inhibited by bumetanide. Studies on permeabilized Calu-3 monolayers revealed 1-EBIO activates both a basolateral membrane K ϩ conductance and an apical membrane Cl Ϫ conductance as HCO Ϫ 3 previously shown in studies on T84 cells (Devor et al., 1996) . CTX and clotrimozole both inhibited the 1-EBIO I sc response as well as the 1-EBIO-activated K ϩ current in permeabilized monolayers. Patch-clamp studies demonstrated the presence of an intermediate conductance, inwardly rectified, Ca ϩ -activated K ϩ channel in Calu-3 cells that was activated by 1-EBIO and blocked by CTX and clotrimozole. We and others have also identified a Ca ϩ -activated K ϩ channel with identical biophysical properties and pharmacological profile in T84 cells (Devor and Frizzell, 1993; Tabcharani et al., 1994; Roch et al., 1995; Devor et al., 1996) . Moreover, Welsh and McCann (1985) and McCann et al. (1990) have already shown that this channel is expressed in native airway epithelial cells and is therefore not just in Figure 11 . Inhibition of K Ca by CTX and clotriomazole. (A) Addition of CTX (50 nM) to the extracellular side of K Ca in an excised, outside-out patch resulted in a complete inhibition of channel activity when the patch was voltage clamped to Ϫ100 mV (inside negative). Patch pipette contained 400 nM free Ca 2ϩ . (B) Addition of clotrimazole (3 M) to the cytoplasmic side of K Ca in an excised inside out patch resulted in a complete inhibition of channel activity at a holding potential of Ϫ100 mV. Other conditions as indicated in Fig. 10 , the arrows indicate the closed state of the channel. epithelial cell lines. Recently, three different groups have cloned the same K ϩ channel, variously referred to as hIK-1, hSK4, and hIK (Ishii et al., 1997; Joiner et al., 1997; Jensen et al., 1998) . These channels have identical biophysical properties and pharmacological profile to the channel observed in canine tracheocytes, T84 cells, and Calu-3 cells. Northern blot analysis has confirmed the presence of the mRNA for hIK-1 in T84 and Calu-3 cells (Devor, D.C., unpublished results) . Thus, we conclude that one site of action of 1-EBIO is the activation of hIK-1 in the basolateral membrane of Calu-3 cells. Permeabilization of monolayers demonstrated 1-EBIO also activates an apical membrane Cl Ϫ channel; however, the identity of the apical membrane Cl Ϫ channel that is activated by 1-EBIO is less certain. Haws et al. (1994) have reported the predominant Cl Ϫ channel observed in Calu-3 cells is a low conductance channel with properties consistent with those of CFTR. 1-EBIO is a benzimidazolinone and other benzimidazolinones (e.g., NS004 and NS1619) have been reported to activate CFTR (Gribkoff et al., 1994; Champigny et al., 1995) . Thus, it is possible that the Cl Ϫ channel activated by 1-EBIO in Calu-3 cells is CFTR. However, further studies will be necessary to confirm this hypothesis.
Calu-3 cells secrete in response to forskolin HCO Ϫ 3 and Cl Ϫ in response to 1-EBIO. However, when the two agonists are added together, anion secretion is dominated by Cl Ϫ secretion and there is a decrease in the net secretion of . Studies with primary cultures of human bronchial epithelial cells lead Smith and Welsh (1992) to suggest that airway epithelia may also switch between and Cl Ϫ secretion. Ashton et al. (1991) have also suggested that pancreatic ductal epithelial cells can be differentially stimulated to secrete or Cl Ϫ . The mechanisms that underlie the switch between and Cl Ϫ secretion are largely unknown. Our results with Calu-3 cells offer some insight and suggest a model (Fig. 12) to explain how the same cell can secrete when stimulated by forskolin and Cl Ϫ when stimulated by 1-EBIO or 1-EBIO plus forskolin.
The first tenet of the model is the presence of an anion channel in the apical membrane that can conduct both and Cl Ϫ . Whether there are two separate channel types, one favoring and activated by forskolin and one favoring Cl Ϫ and activated by 1-EBIO, or a single channel type that conducts both and Cl Ϫ is not clear at this time. Nonselective anion channels have been reported but to our knowledge an epithelial anion channel that favors over Cl Ϫ has HCO Ϫ 3
